NYSEMKT: SRXHSrx Global Inc Stock
$1.92+0.09 (+4.92%)
Updated Aug 14, 2026
SRXH Price
$1.92
Fair Value Price
N/A
Market Cap
$38.91M
52 Week Low
$0.96
52 Week High
$42.61
P/E
-0.04x
P/B
0.27x
P/S
-2.5x
PEG
N/A
Dividend Yield
2.6%
Revenue
-$24.91M
Earnings
-$34.40M
Gross Margin
22.2%
Operating Margin
131.85%
Profit Margin
138.1%
Debt to Equity
0.02
Operating Cash Flow
-$3M
Beta
0.8
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
SRXH Overview
Better Choice Company Inc. offers kibble and canned dog and cat foods, freeze-dried raw dog foods and treats, vegan dog foods and treats, oral care products, as well as chews and grooming products. Its brands are Halo and TruDog. Better Choice primarily sells its products online. Better Choice was founded in 1986 and is based in Tampa, FL.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine SRXH's potential to beat the market
DSell
- Stocks with a Zen Rating of Sell (D) had an average loss of -6.47% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical Care Facility
Industry Rating
A
SRXH
Ranked#42 of 44
Ranked#42 of 44
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $26.61 | A | |
| $532.88 | A | |
| $12.42 | A |
Be the first to know about important SRXH news, forecast changes, insider trades & much more!
SRXH News
Overview
Due Diligence Score
–
Industry Average (31)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how SRXH scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
SRXH is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
SRXH is good value based on its book value relative to its share price (0.27x), compared to the US Medical Care Facilities industry average (5.56x)
P/B vs Industry Valuation
SRXH is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 35 more SRXH due diligence checks available for Premium users.
Valuation
SRXH price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.04x
Industry
17.17x
Market
15.95x
SRXH price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.27x
Industry
5.56x
SRXH is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
SRXH's financial health
Profit margin
Revenue
$3.4M
Net Income
-$4.1M
Profit Margin
-122.1%
SRXH's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
SRXH's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$145.4M
Liabilities
$2.4M
Debt to equity
0.02
SRXH's short-term assets ($65.24M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SRXH's short-term assets ($65.24M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SRXH's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
SRXH's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$956.0k
Investing
-$8.7M
Financing
$25.8M
SRXH's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
SRXH vs Medical Care Facility Stocks
Srx Global Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.